Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical EGFRvIII PeptIDtrIfluoROC 10mg
SDP

Catalog No. 502918543
Encompass_Preferred

An EGFRvIII peptide fragment; binds to MHC class I subtype HLA-A*0201-positive T2 cells at 25 UG/ml; induces antigen presentation in dendritic cells, which stimulates activation of, and IFN-γ production by, CD8+ cytotoxic T lymphocytes; immunization with EGFRvIII peptide, in combination with flagellin B, increases the number of CD8+ T cells and decreases the number of Tregs in the brain, reduces tumor volume, and increases survival rate in an orthotopic GL261 glioblastoma mouse xenograft model

Catalog No. 50-291-8543 Supplier Cayman Chemical Supplier No. 3884610 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An EGFRvIII peptide fragment; binds to MHC class I subtype HLA-A*0201-positive T2 cells at 25 UG/ml; induces antigen presentation in dendritic cells, which stimulates activation of, and IFN-γ production by, CD8+ cytotoxic T lymphocytes; immunization with EGFRvIII peptide, in combination with flagellin B, increases the number of CD8+ T cells and decreases the number of Tregs in the brain, reduces tumor volume, and increases survival rate in an orthotopic GL261 glioblastoma mouse xenograft model

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.